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Abstract: Palladium-catalyzed CN bond forming re-
actions of 6-bromo- as well as 6-chloropurine ribonu-
cleosides and the 2’-deoxy analogues with arylamines
are described. Efficient conversions were observed
with palladium(II) acetate/Xantphos/cesium carbon-
ate, in toluene at 100 8C. Reactions of the bromonu-
cleoside derivatives could be conducted at a lowered
catalytic loading [5 mol% Pd ACHTUNGTRENNUNG(OAc)2/7.5 mol% Xant-
phos], whereas good product yields were obtained
with a higher catalyst load [10 mol% PdACHTUNGTRENNUNG(OAc)2/
15 mol% Xantphos] when the chloro analogue was
employed. Among the examples evaluated, silyl pro-
tection for the hydroxy groups appears better as
compared to acetyl. The methodology has been eval-
uated via reactions with a variety of arylamines and
by synthesis of biologically relevant deoxyadenosine
and adenosine dimers. This is the first detailed analy-
sis of aryl amination reactions of 6-chloropurine nu-
cleosides, and comparison of the two halogenated
nucleoside substrates.
Keywords: amination; CN bond formation; ligands;
nucleosides; palladium; Xantphos
Introduction
Palladium-catalyzed CN bond forming reactions
have become an important type of transformation in
the synthetic repertoire.[1] In this context, we have
been gaining an understanding of and exploiting such
catalyzed amination reactions of nucleosides.[2] The
high biochemical, physiological and medicinal value
of compounds that can arise by alteration of the nu-
cleoside scaffold adds significant importance to the
development of methods for nucleoside modifica-
tion.[3,4]
In 1999 we demonstrated, for the first time, that
N6-aryl-2’-deoxyadenosine analogues could be effi-
ciently synthesized via CN bond-formation using a
suitable Pd-ligand complex.[5] Subsequently, we ana-
lyzed a series of ligands for CC and CN bond for-
mation.[6] This led to the identification of specific li-
gands that were effective for aryl amination. These in-
cluded 2-(dicyclohexylphosphino)-2’-(N,N-dimethyla-
mino)-1,1’-biphenyl and ( )-BINAP. In subsequent
aryl amination work the same two ligands also proved
to be useful in gaining access to N6-(6-benzo[a]pyren-
yl)-2’-deoxyadenosine.[7]
In all these cases, the halopurine nucleoside tested
and used was 6-bromo-9-[2-deoxy-3,5-di-O-(tert-butyl-
dimethylsilyl)-b-d-ribofuranosyl]purine. In compari-
son, there are fewer analyses of the use of the 6-
chloro ACHTUNGTRENNUNGpurine nucleoside analogues in Pd-mediated
amination reactions. Among these, reactions of 6-
chloro-9-[2,3,5-tri-O-(tert-butyldimethylsilyl)-b-d-ribo-
furanosyl]purine using Pd2ACHTUNGTRENNUNG(dba)3/BINAP with either
Cs2CO3 or t-BuOK were evaluated.
[8] Although reac-
tions of alkylamines proceeded well, comparable reac-
tions of arylamines were not efficient. Using Pd-
ACHTUNGTRENNUNG(OAc)2/()-BINAP/Cs2CO3 we have studied the ami-
nation of silyl-protected 6-chloro-9-[2-deoxy-3,5-di-O-
(tert-butyldimethylsilyl)-b-d-ribofuranosyl]purine with
a sterically-demanding alkylamino derivative of a
polycyclic aromatic hydrocarbon.[9] Subsequently we
have synthesized more elaborate carcinogen-nucleo-
side adducts using this chloronucleoside.[10] We have
also studied CN ACHTUNGTRENNUNG(sp2) bond-forming reactions of 6-
bromo- and 6-chloropurine nucleosides with azoles.[11]
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Despite these results, there has not been the devel-
opment of effective Pd-catalyzed aryl amination
methods to involve 6-chloropurine nucleosides. Also,
no comparative performance evaluation of 6-bromo-
and 6-chloropurine nucleosides under Pd-catalyzed
aryl amination conditions has been conducted. In this
context it should be noted that SNAr displacement re-
actions between a 6-bromopurine nucleoside and two
arylamines have been accomplished, but reactions of
corresponding 6-chloro compound are stated to be in-
effective.[12]
Pd catalysis appears to offer a simple, unifying
method for involving both 6-bromo- and 6-chloropur-
ine nucleosides in aryl amination reactions. This
paper reports our studies on such reactions of these
nucleoside derivatives.
Results and Discussion
For the current work, 6-bromo- and 6-chloropurine ri-
bonucleosides as well as the 2’-deoxy analogues were
chosen for analysis. We also wanted to assess silyl and
acetyl protecting groups for the sugar moieties. Thus,
six compounds 1a–2c (Figure 1) became the choices
for the initial experiments. The overall goal was not
the determination of the best conditions for reactions
of each substrate, but rather to find generally optimal
conditions for the aryl amination reactions that can
be applied to the synthesis of a broad class of N6-aryl-
ACHTUNGTRENNUNGadenosine analogues.
Bromo nucleosides 1a–c were conveniently synthe-
sized through a diazotization-bromination proto-
col[11,12] by appropriate modification of a literature
route.[13] Chloro nucleoside 2a[14] was prepared by sily-
lation of 6-chloro-9-(2-deoxy-b-d-ribofuranosyl)pur-
ine[15] whereas 2b[11,16] and 2c were prepared by silyla-
tion and acetylation of commercially available 6-
chloro-9-(b-d-ribofuranosyl)purine. Alternatively, 2c
can be prepared by chlorination of inosine triace-
tate.[17]
With these compounds, we began to evaluate condi-
tions for aryl amination. We selected six ligands, 2-(di-
cyclohexylphosphino)-2’-N,N-(dimethylamino)-1,1’-bi-
phenyl (L1), ( )-BINAP (L2), Xantphos (L3), 2-(di-
cyclohexylphosphino)biphenyl (L4), 2-(di-tert-butyl-
phosphino)biphenyl (L5) and 4-(diphenylphosphino)-
9,9-dimethylxanthene (L6) shown in Figure 2. The
first three were chosen since these have previously
yielded effective amination catalysts for nucleo-
sides,[2,5–11,18–24] whereas L4 and L5 were included due
to their similarity to L1. Monophosphane L6 was in-
cluded for comparison to L3. PdACHTUNGTRENNUNG(OAc)2 and Pd2ACHTUNGTRENNUNG(dba)3
were the metal sources, K3PO4 and Cs2CO3 were
chosen as bases.
Our initially reported work on 1a[5,6] was the start-
ing point upon which the newer results were devel-
oped. Using p-toluidine as a representative amine in
the initial test reactions, the most significant results
(product yields >50%) from several experiments are
shown in Table 1.
Our first attempt was to further tune conditions in
entry 1 using substrate 1a. Use of 10 mol% PdACHTUNGTRENNUNG(OAc)2/
15 mol% L1, under otherwise comparable conditions
to entry 1, resulted in a poor yield (37%, 9 h). Use of
10 mol% Pd2ACHTUNGTRENNUNG(dba)3/30 mol% L1/1.5 molar equiv.
Cs2CO3 in toluene at 100 8C, did not produce an im-
provement (41% yield in 4 h). This led us to consider
L2 as well as L3. Initial reactions were conducted
with 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L2 or L3/1.5 molar
equiv. Cs2CO3, in toluene at 100 8C. Under these con-
ditions, the reaction utilizing L2 gave a 64% yield of
product, whereas that involving L3 gave 89% yield
(entries 2 and 3). We next considered reducing the
Pd/L3 loading by half, and this modification produced
essentially no difference, resulting in an excellent
90% yield of the amination product (entry 4). Under
these best conditions, replacing L3 with L4 or L5 re-
sulted in poorer results (entries 5 and 6).
The foregoing results formed the basis for subse-
quent experiments, and a similar trend was observed
with the ribose derivative 1b, where the lower Pd-
ACHTUNGTRENNUNG(OAc)2/L3 loading gave excellent product recovery
(compare entries 7 and 8). Whether both phosphaneFigure 1. Six nucleoside substrates selected for analysis.
Figure 2. Six ligands selected for analysis.
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units in L3 are critical for an effective catalyst was
next queried. Use of L6 in place of L3 (entry 9) clear-
ly showed that L3 was superior.
Next, optimization of amination conditions with the
chloronucleosides was conducted, starting with 2a.
Use of 10 mol% Pd2ACHTUNGTRENNUNG(dba)3/30 mol% L1 with either
K3PO4 or Cs2CO3 in DME gave ca. 50% product
yields (entries 10 and 11). In contrast, this catalytic
system with Cs2CO3 in PhMe gave a high 80% yield
(entry 12), but replacing Pd2ACHTUNGTRENNUNG(dba)3 with 10 mol% Pd-
ACHTUNGTRENNUNG(OAc)2 lowered the yield to 59% (entry 13). We next
investigated the use of L2. At 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/
15 mol% L2 an excellent 88% product yield was real-
ized (entry 14), which decreased to 67% when the cat-
alytic load was reduced by half (entry 15). When L2
was replaced with L3, the higher and lower catalyst
load produced identical, good results (entries 16 and
17). On the basis of these experiments, substrate 2b
was then investigated. At 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/
15 mol% L2, again an excellent 88% yield of aminat-
ed product was obtained (entry 18), which remained
unaltered when the catalyst load was decreased
(entry 19). Upon replacement of L2 with L3, some
other differences emerged. Use of the higher
10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3 resulted in an excel-
lent 92% yield of product, but reduction of the cata-
lytic load by half produced only a 74% yield (com-
pare entries 20 and 21). Here again presence of 2
phosphane units in L3 proved essential as shown by
the poorer result with L6 (entry 22)
These results indicated some differences in the re-
actions of 2a and 2b. With 2a, the higher and lower
Table 1. Initial results from CN bond-forming reactions of substrates 1a–2c with p-toluidine.
Entry Substrate Pd source (mol%) Ligand (mol%) Base (1.5 molar equiv) Solvent Temp. [8C] Time [h][a] Yield [%][b]
Reactions of bromonucleosides 1a, b with p-toluidine
1 1a Pd2ACHTUNGTRENNUNG(dba)3 (10) L1 (30) K3PO4 DME 80 3 69
[c]
2 1a Pd ACHTUNGTRENNUNG(OAc)2 (10) L2 (15) Cs2CO3 PhMe 100 1 64
3 1a Pd ACHTUNGTRENNUNG(OAc)2 (10) L3 (15) Cs2CO3 PhMe 100 1 89
4 1a Pd ACHTUNGTRENNUNG(OAc)2 (5) L3 (7.5) Cs2CO3 PhMe 100 1 90
5 1a Pd ACHTUNGTRENNUNG(OAc)2 (5) L4 (7.5) Cs2CO3 PhMe 100 6 70
6 1a Pd ACHTUNGTRENNUNG(OAc)2 (5) L5 (7.5) Cs2CO3 PhMe 100 24 56
[d]
7 1b Pd ACHTUNGTRENNUNG(OAc)2 (10) L2 (15) Cs2CO3 PhMe 100 2 76
8 1b Pd ACHTUNGTRENNUNG(OAc)2 (5) L3 (7.5) Cs2CO3 PhMe 100 1 93
9 1b Pd ACHTUNGTRENNUNG(OAc)2 (5) L6 (7.5) Cs2CO3 PhMe 100 7 66
Reactions of chloronucleosides 2a, b with p-toluidine
10 2a Pd2ACHTUNGTRENNUNG(dba)3 (10) L1 (30) K3PO4 DME 80 22 49
11 2a Pd2ACHTUNGTRENNUNG(dba)3 (10) L1 (30) Cs2CO3 DME 80 26 52
12 2a Pd2ACHTUNGTRENNUNG(dba)3 (10) L1 (30) Cs2CO3 PhMe 100 1 80
13 2a Pd ACHTUNGTRENNUNG(OAc)2 (10) L1 (15) Cs2CO3 PhMe 100 1 59
14 2a Pd ACHTUNGTRENNUNG(OAc)2 (10) L2 (15) Cs2CO3 PhMe 100 1 88
15 2a Pd ACHTUNGTRENNUNG(OAc)2 (5) L2 (7.5) Cs2CO3 PhMe 100 1 67
16 2a Pd ACHTUNGTRENNUNG(OAc)2 (10) L3 (15) Cs2CO3 PhMe 100 1 86
17 2a Pd ACHTUNGTRENNUNG(OAc)2 (5) L3 (7.5) Cs2CO3 PhMe 100 1 86
18 2b Pd ACHTUNGTRENNUNG(OAc)2 (10) L2 (15) Cs2CO3 PhMe 100 2 88
19 2b Pd ACHTUNGTRENNUNG(OAc)2 (5) L2 (7.5) Cs2CO3 PhMe 100 2 88
20 2b Pd ACHTUNGTRENNUNG(OAc)2 (10) L3 (15) Cs2CO3 PhMe 100 1 92
21 2b Pd ACHTUNGTRENNUNG(OAc)2 (5) L3 (7.5) Cs2CO3 PhMe 100 1 74
22 2b Pd ACHTUNGTRENNUNG(OAc)2 (10) L6 (15) Cs2CO3 PhMe 100 5 60
Reactions of chloronucleoside 2b with o-toluidine
23 2b Pd ACHTUNGTRENNUNG(OAc)2 (10) L2 (15) Cs2CO3 PhMe 100 1 86 (87
[e])
24 2b Pd ACHTUNGTRENNUNG(OAc)2 (5) L2 (7.5) Cs2CO3 PhMe 100 1 73 (76
[e])
25 2b Pd ACHTUNGTRENNUNG(OAc)2 (10) L3 (15) Cs2CO3 PhMe 100 1 92
Reactions of acetate-protected nucleosides 1c and 2c with p-toluidine
26 1c Pd ACHTUNGTRENNUNG(OAc)2 (5) L3 (7.5) Cs2CO3 PhMe 100 1.5 82
27 2c Pd ACHTUNGTRENNUNG(OAc)2 (10) L3 (15) Cs2CO3 PhMe 100 1.5 62
Reactions of 1a and 2a with p-toluidine using Pd ACHTUNGTRENNUNG(PPh3)4 as catalyst
28 1a Pd ACHTUNGTRENNUNG(PPh3)4 (5) none Cs2CO3 PhMe 100 4 56
29 2a Pd ACHTUNGTRENNUNG(PPh3)4 (5) none Cs2CO3 PhMe 100 5 62
[a] Reactions were monitored by TLC for complete disappearance of the halonucleoside.
[b] Where reported, yield is of isolated and purified products.
[c] Reported in ref.[5]
[d] Reaction was incomplete.
[e] Reaction time was 2 h.
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Pd ACHTUNGTRENNUNG(OAc)2/L3 loads produced comparable results,
whereas this was not the case with Pd ACHTUNGTRENNUNG(OAc)2/L2. The
exact opposite trend was observed with 2b, where the
higher and lower loads of Pd ACHTUNGTRENNUNG(OAc)2/L2 showed com-
parable results, but not with Pd ACHTUNGTRENNUNG(OAc)2/L3. In an at-
tempt to gain additional insight, three other reactions
were conducted between 2b and the sterically hin-
dered o-toluidine (entries 23–25). Reaction of this
amine and 2b catalyzed by 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/
15 mol% L2 gave an 86% product yield, versus 73%
with 5 mol% Pd ACHTUNGTRENNUNG(OAc)2/7.5 mol% L2, both in 1 h.
These yields did not change appreciably when the re-
action was conducted over 2 h (entries 23 and 24,
yields in parentheses). On the other hand use of
10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3 gave an excellent
92% yield (entry 25). A review of the data indicates
that 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3 gave consistent-
ly good results for reactions of both 2a and 2b.
Thus, the combination of PdACHTUNGTRENNUNG(OAc)2/L3/Cs2CO3 in
PhMe, at 100 8C is generally applicable for amination
of 6-bromo- and 6-chloropurine nucleosides. Howev-
er, a lowered catalytic load can be used for the
Table 2. Amination reactions of the bromo- (1a and 1b) and chloronucleosides (2a and 2b) with several amines.
Entry Amine Substrate Conditions,[a] time[b] Product: Yield [%][c]
1 1a A, 1 h 3a : 90
2 1b A, 1 h 4a : 93
3 2a B, 1 h 3a : 86
4 2b B, 1 h 4a : 92
5 1a A, 1 h 3b : 88
6 1b A, 1 h 4b : 92
7 2a B, 1 h 3b : 92
8 2b B, 1 h 4b : 92
9 1a A, 1 h 3c : 79
10 1b A, 1.5 h 4c : 87
11 2a B, 1 h 3c : 72
12 2b B, 1 h 4c : 91
13 1a A, 1 h 3d : 68
14 1b A, 1 h 4d : 84
15 2a B, 1 h 3d : 78
16 2b B, 1 h 4d : 92
17 1a A, 1 h 3e : 87
18 1b A, 1 h 4e : 86
19 2a B, 1 h 3e : 87
20 2b B, 1 h 4e : 93
21 1a A, 1 h 3f : 91
22 1b A, 1 h 4f : 88
23 2a B, 1 h 3f : 95
24 2b B, 1 h 4f : 89
25 1a A, 1 h 3g : 88
26 1b A, 1 h 4g : 84
27 2a B, 1 h 3g : 92
28 2b B, 1 h 4g : 99
[a] Reactions were performed at a nucleoside concentration of 0.1M in the reaction solvent. Conditions A : 5 mol%
Pd ACHTUNGTRENNUNG(OAc)2/7.5 mol% L3/1.5 molar equiv. Cs2CO3, PhMe, 100 8C. Conditions B : 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3/1.5 molar
equiv. Cs2CO3, PhMe, 100 8C.
[b] Reactions were monitored by TLC for complete disappearance of the halonucleoside.
[c] Yield of isolated and purified products.
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former. We also compared reactions of acetate-pro-
tected derivatives 1c and 2c using the best conditions
identified for reactions of the bromo- and chloronu-
cleosides (entries 26 and 27). In both cases, although
reasonable product yields were attained, the results
were not superior to those involving the silyl-protect-
ed derivatives. Finally we tested 5 mol% Pd ACHTUNGTRENNUNG(PPh3)4
under otherwise identical conditions. This Pd(0) cata-
lyst has been used for Suzuki–Miyaura cross-coupling
reactions of nucleosides.[23,25] Both 1a and 2a reacted
with p-toluidine, but these reactions (entries 28 and
29) were inferior to the low catalyst loading experi-
ments with L2 and L3. On the basis of these results,
we then evaluated the amination reactions using the
silylated nucleoside substrates and several amines
with varying electronic and steric properties. These
results are displayed in Table 2.
From the results in Table 2, it is evident that both
bromo- (1a, b) and chloronucleosides (2a, b) are ef-
fective substrates for amination with a variety of aryl-
amines. For reactions of the bromonucleosides 1a and
1b, conditions A [5 mol% Pd ACHTUNGTRENNUNG(OAc)2/7.5 mol% L3]
are reasonable for efficient reactions, and good-to-ex-
cellent yields were observed. Only the reaction of o-
toluidine with 1a gave <70% yield (entry 13). On the
other hand, all reactions with o-anisidine gave satis-
factory results (entries 17–20). The electron-deficient
p-acetylaniline reacted very well (entries 5–8), and
good results were also obtained with m-cyanoaniline
(entries 9–12).
Reactions of the chloronucleosides 2a and 2b under
conditions B [10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3] gave
good-to-excellent results. These data clearly indicate
that such chloronucleosides are excellent coupling
partners in Pd-catalyzed CN bond-forming reactions.
When comparing these catalyzed transformations
to the SNAr chemistry of 6-halopurine nucleosides,
the following are notable. The Pd-catalyzed reactions
of 1b produced comparable yields to displacement re-
actions on 1c,[12] but require 3 times less arylamine.
Also, Pd-catalyzed reactions with the chloronucleo-
sides resulted in amination products, whereas such
chloronucleosides were reported to be unreactive
under SNAr conditions.
[12]
Arylation of nucleosides by aryl bromides had been
challenging until our recent report.[24] Thus, reactivity
properties of nucleosides often do not follow known
trends of simpler aryl systems. With the reactions of
the simple arylamines completed, we next analyzed
the use of nucleosides themselves as the arylamine in
coupling reactions with the halonucleosides. Nucleo-
side dimers are of interest since they can be formed
in vitro by nitrous acid-induced DNA cross-linking.
Such a process could have a physiological role due to
the presence of nitrite in cured meats.[26,27] Pd-cata-
lyzed approaches have been used for the non-biomim-
etic synthesis of adducts produced by DNA cross-link-
ing.[28,29] Among the various nucleoside dimers, deoxy-
guanosine-deoxyguanosine (dG–dG), deoxyadeno-
sine-deoxyguanosine (dA–dG), and deoxyadenosine-
deoxyadenosine (dA–dA), the synthesis of dA–dA
posed particular challenges. For instance, reaction of
1a and 5a using several Pd/L2 complexes were report-
ed to be low yielding, and thus use of the iodo ana-
logue of 1a was necessary.[29] On the basis of our re-
sults, we wanted to reassess the reaction of 1a with 5a
and analyze reactivity of the chloro analogue 2a for
synthesis of dA–dA dimer. We also wanted to com-
pare these reactions to those leading to the adeno-
sine-adenosine (A–A, ribose) dimers (Scheme 1). The
results of these experiments are shown in Table 3.
From Table 3 it becomes clear that 6-bromonucleo-
sides 1a and 1b are good substrates for Pd-catalyzed
amination reactions with the more complex amines 5a
and 5b. Good yields were obtained with 5 mol% Pd-
ACHTUNGTRENNUNG(OAc)2/7.5 mol% L3 (entries 1 and 2), and some im-
provement was attained with the increased catalyst
load of 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3 (entries 3
and 4). More interestingly, chloropurine analogues 2a
and 2b are also highly effective in these reactions and
Scheme 1. Application of the Pd ACHTUNGTRENNUNG(OAc)2/Xantphos system
for the synthesis of the adenine nucleoside dimers.
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provide comparable product yields to the bromopur-
ine nucleoside derivatives at the higher catalyst load-
ing of 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3. Thus, contra-
ry to prior results,[29] our data indicate that it is unnec-
essary to involve the iodo nucleosides in Pd-catalyzed
syntheses of nucleoside dimers.
Since modified nucleosides could possess interest-
ing biological properties, the amination products were
desilylated (see the Supporting Information for de-
tails, and Table S1). The deprotected compounds from
this study as well as those obtained from previously
synthesized compounds[11,23,30] were subjected to a
wide variety of antiviral assays. Unfortunately, none
showed specifically interesting activity at subtoxic
concentrations as shown in Tables S2–S5 of the Sup-
porting Information. Instead, several compounds
showed a mild cytostatic and/or cytotoxic activity
against a variety of cell lines (CC50 or MIC in the 10
to 100 mgmL1 range). Only the desilylated product
from 4f was endowed with a marked cytostatic activi-
ty against CRFK cells (CC50: 4.32 mM). This com-
pound should be further explored for its potential an-
tiproliferative activity against a broad variety of
tumor cell lines. Pd-catalyzed CN and CC bond-
forming reactions have led to this diverse set of com-
pounds for antiviral and cytostatic analysis that would
otherwise not be available.
Conclusions
In conclusion, Pd-catalyzed CN bond formation is
an effective method for access to N6-aryl adenosine
analogues. Herein we show that 5 mol% Pd ACHTUNGTRENNUNG(OAc)2/
7.5 mol% Xantphos is a generally effective catalyst in
combination with Cs2CO3 in PhMe at 100 8C for reac-
tions of 6-bromopurine ribonucleosides as well as the
2’-deoxy analogues. Remarkably, the corresponding 6-
chloropurine nucleosides are also excellent substrates
for such reactions, requiring 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/
15 mol% Xantphos, under otherwise comparable con-
ditions. Finally, the method has been applied to the
synthesis of deoxyadenosine-deoxyadenosine and ade-
nosine-adenosine dimers. Bromo- as well as chloro-
purine ribo- and deoxyribonucleosides are effective
substrates for reactions with protected 2’-deoxyadeno-
sine and adenosine. Therefore, the methodology de-
scribed appears to present broad generality and scope
for nucleoside modification with both 6-bromo and 6-
chloropurine nucleosides.
Experimental Section
Thin layer chromatography was performed on 250 mm silica
plates and column chromatographic purifications were per-
formed on 200–300 mesh silica gel. Ligands L1–L5 and Pd-
ACHTUNGTRENNUNG(OAc)2 were purchased from commercial suppliers. All
other reagents were obtained from commercial sources and
were used without further purification. Toluene was distilled
over Na. Nucleoside substrates were prepared as described
previously. Characterization data for all compounds are pro-
vided in the Supporting Information. 1H NMR spectra were
recorded at 500 MHz in the solvents indicated (when CDCl3
was used, it was deacidified by percolating the solvent
through a bed of solid NaHCO3 and basic alumina). All
proton spectra are referenced to residual protonated solvent
resonance. No attempt has been made to ascertain the posi-
tion of the arylamino proton (NHAr) in the products.
Therefore, this and the aromatic protons are collectively as-
signed as Ar-H. The sugar protons are numbered 1’–5’ be-
ginning at the anomeric carbon and proceeding via the
carbon chain to the primary carbinol carbon.
CN Bond-Formation under Conditions A
Pd ACHTUNGTRENNUNG(OAc)2 (5 mol%), Xantphos (7.5 mol%) and Cs2CO3 (1.5
molar equiv.) were premixed in a small volume of toluene in
an oven-dried, screw-cap vial equipped with a stirring bar.
Bromonucleoside (1 molar equiv., 0.08 mmol of 1a or 1b),
arylamine (2 molar equiv.) and toluene were then added to
the vial so that the final reaction mixture was 0.1M in nu-
cleoside. The vial was flushed with nitrogen gas, sealed with
a Teflon-lined cap, and placed in a sand bath that was main-
tained at 101–102 8C. Reactions were monitored by TLC.
Upon completion, the mixtures were diluted with Et2O
(7 mL) and washed with brine (5 mL). The organic phase
was separated, dried (Na2SO4) and concentrated. Products
were purified by column chromatography on silica gel using
appropriate solvents (listed under individual headings),
evaporated and finally dried under high vacuum to remove
traces of solvent.
CN Bond-Formation under Conditions B
Pd ACHTUNGTRENNUNG(OAc)2 (10 mol%), Xantphos (15 mol%) and Cs2CO3 (1.5
molar equiv.) were premixed in a small volume of toluene in
an oven-dried, screw-cap vial equipped with a stirring bar.
Chloronucleoside (1 molar equiv., 0.08 mmol of 2a or
Table 3. Results from the reactions leading to the dA–dA,
and A–A dimers.
Entry Partners Conditions,[a] time[b] Product: Yield [%][c]
1 1a+5a A, 1 h 6a : 65
2 1b+5b A, 1 h 6b : 70
3 1a+5a B, 1 h 6a : 79
4 1b+5b B, 1 h 6b : 84
3 2a+5a B, 1 h 6a : 77
4 2b+5b B, 1 h 6b : 81
[a] Reactions were performed at a nucleoside concentration
of 0.1M in the reaction solvent. Conditions A : 5 mol%
Pd ACHTUNGTRENNUNG(OAc)2/7.5 mol% L3/1.5 molar equiv. Cs2CO3, PhMe,
100 8C. Conditions B : 10 mol% Pd ACHTUNGTRENNUNG(OAc)2/15 mol% L3/
1.5 molar equiv. Cs2CO3, PhMe, 100 8C.
[b] Reactions were monitored by TLC for complete disap-
pearance of the halonucleoside.
[c] Yield of isolated and purified products.
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0.085 mmol of 2b), amine (2 molar equiv.) and toluene were
then added to the vial so that the final reaction mixture was
0.1M in nucleoside. The vial was flushed with nitrogen gas,
sealed with a Teflon-lined cap, and placed in a sand bath
that was maintained at 101–102 8C. Reactions were moni-
tored by TLC. Upon completion, work-up as above and
column chromatography on silica gel using appropriate sol-
vents yielded the amination products.
Biological Assays
The antiviral assays, other than the anti-HIV assays, were
based on inhibition of virus-induced cytopathicity in HEL
[herpes simplex virus type 1 (HSV-1) (KOS), HSV-2 (G),
vaccinia virus, vesicular stomatitis virus, cytomegalovirus
(HCMV) and varicella-zoster virus (VZV)], Vero (parain-
fluenza-3, reovirus-1, Sindbis virus and Coxsackie B4),
HeLa (vesicular stomatitis virus, Coxsackie virus B4, and
respiratory syncytial virus), Crandel–Rees feline kidney
(CRFK) [feline coronavirus (FIPV) and feline herpes virus]
or MDCK [influenza A (H1N1; H3N2) and influenza B] cell
cultures. Confluent cell cultures (or nearly confluent for
MDCK cells) in microtiter 96-well plates were inoculated
with 100 CCID50 of virus (1 CCID50 being the virus dose to
infect 50% of the cell cultures) in the presence of varying
concentrations (100, 20, 4, … mgmL1) of the test com-
pounds. Viral cytopathicity was recorded as soon as it
reached completion in the control virus-infected cell cul-
tures that were not treated with the test compounds. The
minimal cytotoxic concentration (MCC) of the compounds
was defined as the compound concentration that caused a
microscopically visible alteration of cell morphology. The
CC50 was defined as the compound concentration that re-
sulted in a 50% reduction of the MTT- or MTS-directed
(blue) viability staining of the (CRFK and MDCK) cell cul-
tures. The methodology of the anti-HIV assays was as fol-
lows: human lymphocyte MT-4 cells (ca. 3105 cells/mL)
were infected with 100 CCID50 of HIV ACHTUNGTRENNUNG(IIIB) or HIV-2-
ACHTUNGTRENNUNG(ROD)/mL and seeded in 200 mL wells of a microtiter plate
containing appropriate dilutions of the test compounds.
After 4 days of incubation at 37 8C, virus-induced cytopa-
thicity was recorded with the MTT dye staining method.
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